相关实验视频
Updated: Jun 27, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
15.7K
在瘤微环境中的电荷逆转纳米药物输送系统:机制,挑战和治疗应用
Yizhu Liang1, Jiashuai Wu1, Yutong Yan2
1Innovation Institute, China Medical University, Shenyang 110122, China.
International journal of molecular sciences
|September 28, 2024
概括
电荷逆转纳米药物递送系统 (CRNDDS) 通过响应瘤微环境,提供先进的癌症治疗. 这些系统增强了药物输送,改善了针对癌症治疗的治疗结果和诊断准确性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 电荷逆转纳米药物输送系统 (CRNDDS) 越来越多地用于化疗.
- 这些系统提供有针对性的药物输送,以提高癌症治疗效率.
研究的目的:
- 审查癌症治疗中CRNDDS的最新进展.
- 阐明电荷逆转机制及其在瘤向中的作用.
- 探索CRNDDS的诊断和治疗潜力和局限性.
主要方法:
- 关于CRNDDS在癌症治疗中的最新文献的综述.
- 分析电荷逆转机制 (酸性,氧化还原性,酶反应性).
- 探索CRNDDS与瘤微环境刺激的相互作用.
主要成果:
- CRNDDS在响应瘤特异性刺激 (如酸性pH和氧化还原潜力) 时表现出电荷转换.
- 这些系统表现出瘤组织的增强积累和透.
- 通过利用瘤微环境特征来提高治疗效率和诊断准确度.
结论:
- CRNDDS代表了针对性癌症治疗和诊断的有希望的策略.
- 电荷逆转机制通过利用独特的瘤生理学来增强药物输送.
- 对CRNDDS的进一步研究有可能为新的癌症治疗方法提供潜力.
相关概念视频
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

